Handa Therapeutics LLC.: Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO Tablets
PHYRAGO Represents the First and Only Improved Version of SPRYCEL® That Can Be Safely Co-administered With Gastric Acid-Reducing Agents TAIPEI, TAIWAN / ACCESSWIRE / January 15, 2025 / Handa Pharmaceu ...
Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO (dasatinib) Tablets
TAIPEI, TAIWAN / ACCESSWIRE / January 15, 2025 / Handa Pharmaceuticals, Inc. ("Handa") (6620.TWO) announced that its U.S.
Medscape19h
Gaviscon® vs. Omeprazole in Symptomatic Treatment of Moderate Gastroesophageal Reflux
Background Medical management of GERD mainly uses proton pump inhibitors. Alginates also have proven efficacy. The aim of this trial was to compare short-term efficacy of an alginate (Gaviscon ...
Medscape19h
Room-temperature Storage of Medications Labeled for Refrigeration
This table may help to avoid unnecessary drug loss and expenditures due to improper storage temperatures. Although a full discussion of methods of stability information is beyond the scope of this ...
gadgets36019h
HP Tablets
The company's printers and cartridges are a also big part of its business. HP's latest mobile launch is the 11-inch Tablet PC. The tablet was launched in 22nd September 2021. The tablet comes with a ...